Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of interleukin-1 receptor antagonist in severe traumatic brain injury
2005-005707-42Phase 2Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- May 2007
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of anakinra in traumatic brain injury (TBI), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: Safety of subcutaneously administered IL-1ra. Started May 2007; status: completed.
02
Drugs
anakinra
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on 2005-005707-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005707-42.